tiprankstipranks
Advertisement
Advertisement

HK:0719 Stock Latest News

Shandong Xinhua Pharma Q1 Profit Drops Despite Stable Revenue and Asset Base
Company AnnouncementsShandong Xinhua Pharma Q1 Profit Drops Despite Stable Revenue and Asset Base
8d ago
Xinhua Pharmaceutical Secures Approval to Take Over Potassium Chloride Granules Marketing Rights
PremiumCompany Announcements
Xinhua Pharmaceutical Secures Approval to Take Over Potassium Chloride Granules Marketing Rights
12d ago
Shandong Xinhua Pharmaceutical Wins NMPA Approval for Bumetanide Injection
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Wins NMPA Approval for Bumetanide Injection
21d ago
Shandong Xinhua Pharma Sets Board Meeting to Review Q1 2026 Results
PremiumCompany Announcements
Shandong Xinhua Pharma Sets Board Meeting to Review Q1 2026 Results
21d ago
Xinhua Pharmaceutical Wins NMPA Approval for New Electrolyte Injection
PremiumCompany Announcements
Xinhua Pharmaceutical Wins NMPA Approval for New Electrolyte Injection
29d ago
Xinhua Pharmaceutical Wins Approval to Take Over Galculus Bovis and Metronidazole Capsule Rights
PremiumCompany AnnouncementsXinhua Pharmaceutical Wins Approval to Take Over Galculus Bovis and Metronidazole Capsule Rights
1M ago
Shandong Xinhua Pharmaceutical Announces Retirement of Non-Executive Director
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Announces Retirement of Non-Executive Director
1M ago
Shandong Xinhua Pharmaceutical Sets Out Board and Committee Structure
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Sets Out Board and Committee Structure
1M ago
Shandong Xinhua Pharma Moves to Update Articles After Share Capital Increase
PremiumCompany Announcements
Shandong Xinhua Pharma Moves to Update Articles After Share Capital Increase
1M ago
Shandong Xinhua Pharmaceutical Proposes RMB 0.15 Final Dividend for 2025
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Proposes RMB 0.15 Final Dividend for 2025
1M ago
Shandong Xinhua Pharmaceutical Publishes Audited 2025 Annual Results
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Publishes Audited 2025 Annual Results
1M ago
Shandong Xinhua Unit Wins NMPA Approval for Ibuprofen Granules
PremiumCompany Announcements
Shandong Xinhua Unit Wins NMPA Approval for Ibuprofen Granules
1M ago
Shandong Xinhua Pharmaceutical Wins Approval to Take Over Ezetimibe Marketing Rights
PremiumCompany AnnouncementsShandong Xinhua Pharmaceutical Wins Approval to Take Over Ezetimibe Marketing Rights
2M ago
Shandong Xinhua Pharma Sets March 27 Board Meeting to Approve 2025 Results
Premium
Company Announcements
Shandong Xinhua Pharma Sets March 27 Board Meeting to Approve 2025 Results
2M ago
Shandong Xinhua Unit Wins China Approval for Saxagliptin-Metformin Tablets
Premium
Company Announcements
Shandong Xinhua Unit Wins China Approval for Saxagliptin-Metformin Tablets
2M ago
Shandong Xinhua Pharmaceutical Wins Approval for Entacapone Tablets in China
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Wins Approval for Entacapone Tablets in China
2M ago
Shandong Xinhua Pharmaceutical Wins NMPA Approval for Glucosamine Sulfate Capsules
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Wins NMPA Approval for Glucosamine Sulfate Capsules
3M ago
Shandong Xinhua Pharmaceutical Drops Planned Equity Acquisition with Novo Sana
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Drops Planned Equity Acquisition with Novo Sana
3M ago
Shandong Xinhua Pharmaceutical Tightens Audit Committee Governance Framework
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Tightens Audit Committee Governance Framework
4M ago
Shandong Xinhua Pharmaceutical Tightens Governance With Revised Nomination Committee Charter
PremiumCompany AnnouncementsShandong Xinhua Pharmaceutical Tightens Governance With Revised Nomination Committee Charter
4M ago
Shandong Xinhua Pharmaceutical Updates Remuneration and Appraisal Committee Mandate
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Updates Remuneration and Appraisal Committee Mandate
4M ago
Shandong Xinhua Pharmaceutical Wins China Approval for Valsartan Hypertension Capsules
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Wins China Approval for Valsartan Hypertension Capsules
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >